Abstract A070: Artificial intelligence applications in cancer care: Algorithmic bias impacts health equity

Abstract The most recent global trend shows a gradual and steady increase in artificial intelligence (AI)-related healthcare research over the years. There are notable spikes in activity around late 2021 and early 2022, followed by a decline and then another surge in mid-2023. This suggests fluctuating interest and investment in AI implementation in cancer healthcare research on a global scale. The overall upward trend in worldwide AI healthcare research reflects the growing recognition of AI's potential to revolutionize healthcare practices. Our Fischer's combined probability test results in a P-value of 0.000019. AI’s integration into cancer raises significant ethical concerns. Algorithmic biases could lead to disparities in care delivery, while inadequate data security measures might compromise patient privacy. Additionally, fears of job displacement necessitate proactive retraining programs to ensure that AI complements rather than replaces the workforce. Further research should focus on creating guidelines for ethical AI use, increasing training opportunities for healthcare professionals, and scaling AI technologies across diverse cancer healthcare settings with the acknowledgement of ethical considerations, human collaboration, & continued research and development. Citation Format: SDANISH KADIR, Noushad Javed. Artificial intelligence applications in cancer care: Algorithmic bias impacts health equity [abstract]. In: Proceedings of the 18th AACR Conference on the Science of Cancer Health Disparities; 2025 Sep 18-21; Baltimore, MD. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2025;34(9 Suppl):Abstract nr A070.

Authors

Institutions

Publication Details

Journal
Cancer Epidemiology Biomarkers & Prevention
Published
2025-09-18
DOI
https://doi.org/10.1158/1538-7755.disp25-a070
Primary Topic
COVID-19 and healthcare impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract A070: Artificial intelligence applications in cancer care: Algorithmic bias impacts health equity

Md. Noushad Javed, SDanish Kadir
Cancer Epidemiology Biomarkers & Prevention
COVID-19 and healthcare impacts
article

Abstract A070: Artificial intelligence applications in cancer care: Algorithmic bias impacts health equity

Md. Noushad Javed, SDanish Kadir
article en

Abstract

Abstract The most recent global trend shows a gradual and steady increase in artificial intelligence (AI)-related healthcare research over the years. There are notable spikes in activity around late 2021 and early 2022, followed by a decline and then another surge in mid-2023. This suggests fluctuating interest and investment in AI implementation in cancer healthcare research on a global scale. The overall upward trend in worldwide AI healthcare research reflects the growing recognition of AI's potential to revolutionize healthcare practices. Our Fischer's combined probability test results in a P-value of 0.000019. AI’s integration into cancer raises significant ethical concerns. Algorithmic biases could lead to disparities in care delivery, while inadequate data security measures might compromise patient privacy. Additionally, fears of job displacement necessitate proactive retraining programs to ensure that AI complements rather than replaces the workforce. Further research should focus on creating guidelines for ethical AI use, increasing training opportunities for healthcare professionals, and scaling AI technologies across diverse cancer healthcare settings with the acknowledgement of ethical considerations, human collaboration, & continued research and development. Citation Format: SDANISH KADIR, Noushad Javed. Artificial intelligence applications in cancer care: Algorithmic bias impacts health equity [abstract]. In: Proceedings of the 18th AACR Conference on the Science of Cancer Health Disparities; 2025 Sep 18-21; Baltimore, MD. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2025;34(9 Suppl):Abstract nr A070.

Cancer Epidemiology Biomarkers & PreventionVol. 34(9_Supplement)
The University of Texas Rio Grande Valley (US)
Openalex Percentile: Top 65%
COVID-19 and healthcare impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.